Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents

International Journal of Pharmaceutics

Volumn 384, Issue 1-2, 2010, Pages 93-99

  Muela, Susana ^a   Escalera, Begoña ^a   Peña, M Ángeles ^a   Bustamante, Pilar ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

DSC; Solid dispersions; Solubility parameters; Solubility prediction; Solvent mixtures; Thiabendazole

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; DRUG CARRIER; POVIDONE; SOLVENT; TIABENDAZOLE; WATER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; DRUG STRUCTURE; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; TEMPERATURE;

CHEMISTRY, PHARMACEUTICAL; DRUG SYNERGISM; SOLUBILITY; SOLVENTS; TEMPERATURE; THIABENDAZOLE;

EID: 70649101162     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.10.001     Document Type: Article

References (30)

1. Barton A.F.M. Handbook of Solubility Parameters and Other Cohesion Parameters (1991), CRC Press, Boca Raton, FL pp. 24-38 and 96-103
2. Bustamante P., Escalera B., Martin A., and Selles E. A modification of the extended Hildebrand approach to predict the solubility of structurally related drugs in solvent mixtures. J. Pharm. Pharmacol. 45 (1993) 253-257
3. Bustamante P., Ochoa R., Reillo A., and Escalera J.B. Chameleonic effect of sulfanilamide and sulfamethazine in solvent mixtures. Solubility curves with two maxima. Chem. Pharm. Bull. 42 (1994) 1129-1133
4. Bustamante P., Navarro J., Romero S., and Escalera B. Thermodynamic origin of the solubility profile of drugs showing one or two maxima against the polarity of aqueous and non-aqueous mixtures: niflumic acid and caffeine. J. Pharm. Sci. 91 (2002) 874-883
5. Caykara T. Solubility parameters of cross-linked poly(N-vinyl-2-pyrrolidone-co-crotonic acid) copolymers prepared by gamma-ray-induced polymertization technique. J. Macromol. Sci. Appl. Chem. A 41 (2004) 971-979
6. El-Banna H.M., Daabis N.A., Mortada L.M., and Abd-Elfattah S. Physicochemical study of drug binary systems part 3: tolbutamide-urea and tolbutamide-mannitol systems. Pharmazie 30 (1975) 788-792
7. Escalera J.B., Bustamante P., and Martin A. Predicting the solubility of drugs in solvent mixtures: multiple solubility maxima and the chameleonic effect. J. Pharm. Pharmacol. 46 (1994) 172-175
8. Escalera J.B., Peña M.A., Romero S., Reíllo A., and Bustamante P. Cálculo de los parámetros de solubilidad de dos anti-inflamatorios. ácido mefenámico y acetanilide. Ind. Farm. 3 (1999) 84-88
9. Fedors R.F. A method for estimating both the solubility parameters and molar volumes of liquids. Polym. Eng. Sci. 14 (1974) 147-154
10. Ford J.L., and Rubinstein M.H. Preparation, properties and aging of tablets prepared from the chlorpropamide-urea solid dispersion. Int. J. Pharm. 8 (1981) 311-322
11. Greenhalgh D.J., Williams A.C., Timmins P., and York P. Solubility parameters as predictors of miscibility in solid dispersion. J. Pharm. Sci. 88 (1999) 11
12. Habib M.J. Pharmaceutical Solid Dispersion Technology (2001), Technomic Publishing Go., Inc., Lancaster, PA, USA
13. Hildebrand J.M., Prausnitz J.M., and Scott R.L. Regular and Related Solutions (1970), Van Nostrand Reinhold, New York
14. Hintze J.L. Number Cruncher Statistical Systems (NCSS) (2001), Kaysville, Utah
15. Jouyban A., Romero S., Chan H., Clark B.J., and Bustamante P. A cosolvency model to predict solubility of drugs at several temperatures from a limited number of solubility measurements. Chem. Pharm. Bull. 50 (2002) 594-599
16. Jung J.Y., Dong Yoo S., Lee S.H., Kim K.H., Yoon D.S., and Lee K.H. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm. 187 (1999) 209-218
17. Karger B.L., Snyder L.R., and Eon C. An expanded solubility parameter treatment for classification and use of chromatographic solvents and adsorbents. Parameters for dispersion, dipole and hydrogen bonding interactions. J. Chromatogr. 125 (1976) 71-88
18. Li A., Tabibi E., and Yalkowsky S.H. Combined effect of complexation and pH on solubilization. J. Pharm. Sci. 87 (1998) 1535-1537
19. Li A., Tabibi E., and Yalkowsky S.H. Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants. J. Pharm Sci. 88 (1999) 945-947
20. Lin H., and Nash R.A. An experimental method for determining the Hildebrand solubility parameter of organic non-electrolytes. J. Pharm. Sci. 82 (1993) 1018-1026
21. Liu L., and Wang X. Improved dissolution of oleanolic acid with ternary solid dispersions. AAPS Pharm. Sci. Technol. 8 (2007) 1-5
22. Martin A., Bustamante P., and Chun A.H.C. Physical Pharmacy. 4th ed. (1993), Lea and Febiger, Philadelphia p. 212
23. Mura P., Manderioli A., Bramanti G., and Ceccarelli L. Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm. 22 (1996) 909-916
24. Mura P., Faucci M.T., Manderioli A., Bramanti G., and Parrini P. Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm. 25 (1999) 257-264
25. Peña M.A., Reíllo A., Escalera B., and Bustamante P. Solubility parameter of drugs for predicting the solubility profile type within a wide polarity range in solvent mixtures. Int. J. Pharm. 321 (2006) 155-161
26. Peña, M.A., Escalera, B., Reíllo, A., Sánchez, A.B., Bustamante, P., 2009. Thermodynamics of cosolvent action: phenacetin, salicylic acid and probenecid.
27. Rowe R.C. Polar/nonpolar interactions in the granulation of organic substrates with polymer binding agents. Int. J. Pharm. 56 (1989) 117-124
28. Sethia S., and Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272 (2004) 1-10
29. Sugimoto I., Kuchiki A., and Nakagawa H. Stability of nifedipine-poly(vinylpyrrolidone) coprecipitate. Chem. Pharm. Bull. 29 (1981) 1715-1723
30. Tantishaiyakul V., Kaewnopparat N., and Ingkatawornwong S. Pepperties of solid dispersion of piroxicam in polyvinympyrrolidone K-30. Int. J. Pharm. 143 (1996) 59-66